Patent · US Active

Methods of administering neutralizing anti-protease nexin-1 antibodies to treat hemophilia A

US10851176B2 · kind B2 · utility

0Cited by
0References
4Claims
0Family size

Assignees

Inventors

Key dates

Filing dateApr 12, 2016
Grant dateDec 1, 2020
Priority date
Expiry dateJan 12, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/76
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a method and compositions for the treatment of haemorrhagic diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.